companydata.dkNovo Nordisk North America Operations A/S: Financial statements 2014
CVR: 33761201
Novo Nordisk North America Operations A/S (CVR 33761201) has filed annual accounts for 2014. In 2014, the company reported a net result of DKK -21,000 compared with DKK -27,000 the year before. Equity amounted to DKK 424,000. The solvency ratio was 92.4%.
- Profit/Loss
- -21,000 kr.
- Equity
- 424,000 kr.
- Total Assets
- 459,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | - | -21 t. | 424 t. | - |
| 2013 | - | - | -27 t. | 445 t. | - |
| 2012 | - | - | -17 t. | 472 t. | - |
Keep an eye on Novo Nordisk North America Operations A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
As of July 1, 2014, Karsten Munk Knudsen is registered as director of Novo Nordisk North America Operations A/S.
As of July 1, 2014, Lars Green has stepped down as director of Novo Nordisk North America Operations A/S.
Novo Nordisk North America Operations A/S has published its annual report for 2013. The net result was DKK -27,000.
About Novo Nordisk North America Operations A/S
Novo Nordisk North America Operations A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 2011. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named Novo Nordisk Invest 3 A/S and NOVO NORDISK REGION NORTH AMERICA II A/S. The management consists of Anders Rytter Mikkelsen. The company is owned by NOVO NORDISK A/S. In 2025, the company reported a gross profit of DKK -59,000 and a net result of DKK -74,142,000 compared with DKK -89,167,000 the year before. Equity amounted to DKK 60,045,000.